HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yun Liang Selected Research

berbamine (penduline)

12/2018Novel synthetic 4-chlorobenzoyl berbamine inhibits c-Myc expression and induces apoptosis of diffuse large B cell lymphoma cells.
7/2011Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity.
12/2009Berbamine, a novel nuclear factor kappaB inhibitor, inhibits growth and induces apoptosis in human myeloma cells.
7/2009The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.
4/2009Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo.
1/2009[Berbamine induces apoptosis of multiple myeloma RPMI 8226 cells by activating GADD45/JNK pathway].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yun Liang Research Topics

Disease

35Neoplasms (Cancer)
10/2022 - 04/2009
10Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2022 - 12/2004
10Neoplasm Metastasis (Metastasis)
01/2022 - 12/2009
9Leukemia
11/2019 - 07/2005
7Psoriasis (Pustulosis Palmaris et Plantaris)
01/2018 - 01/2016
6Inflammation (Inflammations)
10/2021 - 03/2008
5Multiple Myeloma
10/2020 - 10/2006
4Hemorrhage
06/2022 - 05/2017
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 03/2014
3Infections
05/2022 - 06/2015
3Carcinoma (Carcinomatosis)
01/2022 - 01/2017
3Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2017
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2019 - 06/2015
3Cysts
09/2012 - 08/2010
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
07/2011 - 07/2005
2Atherosclerosis
11/2021 - 03/2017
2Adenocarcinoma of Lung
12/2020 - 11/2020
2Lung Neoplasms (Lung Cancer)
12/2020 - 03/2019
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2020 - 01/2019
2Stomach Neoplasms (Stomach Cancer)
01/2020 - 01/2020
2Cleft Lip (Harelip)
07/2019 - 10/2010
2Congenital Abnormalities (Deformity)
07/2019 - 10/2010
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 11/2018
2Colonic Neoplasms (Colon Cancer)
03/2016 - 01/2016
2Body Weight (Weight, Body)
04/2015 - 08/2010
1Neuroblastoma
06/2022
1Pancreatic Fistula (Pancreatic Fistulas)
05/2022
1Brain Neoplasms (Brain Tumor)
05/2022
1Diabetes Mellitus
01/2022
1Hyperglycemia
01/2022
1Dehydration (Water Stress)
08/2021
1Fibrosis (Cirrhosis)
01/2021

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2005
6Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2018
6berbamine (penduline)IBA
12/2018 - 01/2009
5Biological ProductsIBA
06/2022 - 10/2013
5AntigensIBA
01/2022 - 11/2008
5Cisplatin (Platino)FDA LinkGeneric
06/2020 - 11/2010
5ChemokinesIBA
01/2020 - 02/2017
4Messenger RNA (mRNA)IBA
11/2020 - 10/2006
4Pharmaceutical PreparationsIBA
10/2020 - 03/2008
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2019
3Circular RNAIBA
12/2020 - 01/2020
3CytokinesIBA
11/2020 - 01/2016
3LigandsIBA
03/2019 - 02/2017
2Tretinoin (Retinoic Acid)FDA LinkGeneric
10/2022 - 01/2015
2Hepatitis B Surface Antigens (HBsAg)FDA Link
06/2022 - 10/2020
2CarbohydratesIBA
01/2022 - 01/2018
2CateninsIBA
01/2022 - 01/2017
2Untranslated RNA (Noncoding RNA)IBA
01/2022 - 01/2017
2Phosphorus (Red Phosphorus)IBA
08/2021 - 01/2009
2Long Noncoding RNAIBA
11/2020 - 01/2017
2PlatinumIBA
06/2020 - 11/2018
2CX3C Chemokine Receptor 1IBA
01/2020 - 02/2017
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 06/2015
2HomoharringtonineIBA
06/2019 - 06/2015
2Immunoglobulin G (IgG)IBA
01/2019 - 12/2011
2Iodine-125IBA
01/2019 - 01/2019
2RNA (Ribonucleic Acid)IBA
12/2017 - 01/2016
2GlucocorticoidsIBA
01/2017 - 12/2015
2Interleukin-17 (Interleukin 17)IBA
12/2016 - 01/2016
2Monoclonal AntibodiesIBA
03/2014 - 12/2011
2Oxygen (Dioxygen)IBA
12/2011 - 01/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2011 - 06/2009
2Imatinib Mesylate (Gleevec)FDA Link
07/2009 - 04/2009
2Fatty Acid Synthases (Fatty Acid Synthase)IBA
06/2008 - 10/2006
2CeruleninIBA
06/2008 - 10/2006
1Immune Checkpoint InhibitorsIBA
10/2022
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2022
1Blood Glucose (Blood Sugar)IBA
01/2022
1APOBEC-1 DeaminaseIBA
01/2022
1Cytidine DeaminaseIBA
01/2022
1Matrix Metalloproteinases (MMPs)IBA
11/2021
1Ferritins (Ferritin)IBA
11/2021
1InterleukinsIBA
11/2021
1Fluorescent Dyes (Fluorescent Probes)IBA
10/2021
1coumarinIBA
10/2021
1Flame Retardants (Fire Retardants)IBA
08/2021
1NitrogenIBA
08/2021
1Chimeric Antigen ReceptorsIBA
01/2021
1Sodium Glutamate (Accent)IBA
01/2021
1Sirtuin 1IBA
12/2020
1extracellular matrix receptorIBA
11/2020
1Cell Adhesion MoleculesIBA
11/2020
1Cytokine Receptors (Cytokine Receptor)IBA
11/2020
1Bortezomib (Velcade)FDA Link
10/2020
1B7-H1 AntigenIBA
06/2020

Therapy/Procedure

8Radiotherapy
05/2022 - 08/2010
6Therapeutics
01/2022 - 06/2008
5Drug Therapy (Chemotherapy)
06/2020 - 12/2011
3Pancreaticoduodenectomy
05/2022 - 09/2019
3Neoadjuvant Therapy
06/2020 - 03/2016
2General Anesthesia
07/2019 - 05/2017
2Brachytherapy
01/2019 - 12/2004
2Transplantation
01/2019 - 01/2018
2Chemoradiotherapy
07/2012 - 03/2011
1Immunotherapy
10/2022
1Perioperative Period
01/2021
1Aftercare (After-Treatment)
10/2020
1Palliative Care (Palliative Therapy)
01/2020